Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells
NCT04313322
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Use of Stem Cells for COVID-19 Treatment
Interventions
BIOLOGICAL:
WJ-MSCs
Sponsor
Stem Cells Arabia